B

Beeline Medicines

Clinical-stage biotech developing precision autoimmune therapies

Vice President - Medical Affairs

Biology & BiotechUpdated on Nov 10
Full-timeRemote in USA

About the Job

Requirements

  • A doctoral degree (MD, DO, Ph.D., PharmD, etc.) is required.
  • 10+ years of progressive Medical Affairs leadership in the pharmaceutical and/or biotechnology industry is required.
  • 5+ years managing multiple teams and/or functions, such as MSLs, RWE, or medical information, at the director level or above is required.
  • Experience building, scaling, and matrixing a Medical Affairs organization, including leading global MSL/field medical teams and data generation activities across multiple therapeutic programs and product launches, is required.
  • Experience with label-enabling Phase 3b and 4 trial design and execution is required, along with a demonstrated track record of successful interactions with global health authorities such as FDA, EMA, PMDA, and CDE.
  • Deep knowledge of Medical Affairs compliance frameworks, such as the PhRMA Code and OIG guidance, applicable to field medical and RWE activities is required.
  • A strong understanding of field medical operations, KOL engagement models, and advisory board execution is required.
  • Working knowledge of real-world evidence generation and observational and interventional study design and execution is required.
  • Executive leadership skills, including building and scaling Medical Affairs functions, are required.
  • Strategic thinking and the ability to align Medical Affairs strategy with broader corporate objectives are required.
  • The ability to drive alignment with adjacent functions without direct reporting authority over them is required.
  • Sound judgment balancing scientific integrity, compliance, and commercial considerations is required.
  • Communication and relationship-building skills with KOLs, internal leadership, and external stakeholders are required.
  • The position may require travel of 30% or more as needed, including occasional overnight stays.
  • Relocation is available.

Responsibilities

  • Provide input and lead implementation of the Medical Affairs strategy across the product portfolio, including pre- and post-launch activities.
  • Develop and oversee HCP engagement strategy, interactions, advisory boards, and consulting activities.
  • Identify data-generation needs and develop appropriate strategies, such as Phase 3b, Phase 4, and real-world evidence approaches, for products in development and lifecycle management activities.
  • Provide technical opinion, appraisal, and oversight of sponsored research agreements and investigator-initiated trials.
  • Review and provide recommendations at relevant governance forums for grants and sponsorship requests, and oversee relevant processes.
  • Partner with Clinical Development, Regulatory, Commercial, and Market Access on cross-functional launch and lifecycle planning.
  • Build, lead, and develop the Medical Affairs function, ensuring relevant processes and tools are in place for effective execution of medical strategy.
  • Ensure Medical Affairs group activities comply with applicable laws, regulations, and industry codes of conduct, including reviewing and giving final approval for external company-facing materials with HCPs and allied professionals.
  • Represent Field Medical and Epidemiology/RWE in due diligence and business development activities.
  • Serve as a senior scientific spokesperson at external congresses and with healthcare stakeholders.
  • Perform other duties and responsibilities as assigned.

Desired Qualifications

  • Medical degree (MD or DO) board certification in immunology, rheumatology, internal medicine, or a related specialty, with clinical experience in autoimmune disease, is strongly preferred.
  • Global Medical Affairs experience, including familiarity with cross-regional regulatory and commercial dynamics, is preferred.

About the Company

Beeline Medicines

Clinical-stage biotech developing precision autoimmune therapies

Beeline Medicines focuses on precision therapies for autoimmune and inflammatory diseases, advancing a portfolio of in-licensed programs from Bristol Myers Squibb with strong backing from Bain Capital. Its lead, afimetoran, is an oral TLR7/8 inhibitor for lupus, with lomedeucitinib as an allosteric TYK2 inhibitor and two IND-stage biologics targeting IL-18 and IL-10 pathways to modulate immune signaling. The company differentiates itself by combining externally sourced programs with a leadership team experienced in drug development and commercialization, pursuing multiple mechanism-driven candidates rather than a single modality, supported by substantial early funding. Its goal is to move its clinical-stage therapies toward pivotal trials and bring targeted immune-modulating treatments to patients, beginning with completing Phase 2 for afimetoran in late 2026 and following with a pivotal program.

Company size
51-200
Company stage
Series A
Total funding
$426.3M
Headquarters
Stamford, CT
Founded
2025

Recently Posted Jobs

Explore more opportunities at Beeline Medicines

See more jobs